Frontlight ResearchEarly access
What researchers published on Chronic lymphocytic leukaemia
6,050 papers, newest first.
Showing 20 of 6,050
ReviewA Value-Based Framework for CLL Care: Results of a Scoping Review.Cancers
Factors Affecting Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia: A Single-Center Retrospective Cohort Study.Diagnostics (Basel, Switzerland)
Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum.Cancers
ReviewArtificial Intelligence in Chronic Lymphocytic Leukemia: From Prognostic Biomarkers to Individualized Treatment Selection.Diagnostics (Basel, Switzerland)
Late-Onset Invasive Aspergillosis Following Acalabrutinib in 2 Patients With Chronic Lymphocytic Leukemia: A Case Report.Open forum infectious diseases
Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter-Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint Interpretation.European journal of haematology
Case reportExtensive Native Aortic Valve Infiltration and Early Bioprosthetic Valve Degeneration in Low-Grade Chronic Lymphocytic Leukemia.JACC. Case reports
Fit for the fight: BTK inhibitors prime CAR T cells in CLL.Blood
Rapid identification of the high-risk IGLV3-21R110 subgroup of chronic lymphocytic leukemia by flow cytometry.Haematologica
Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia.Haematologica
Intercellular transfer of FOLR2 from nurse-like cells fuels chronic lymphocytic leukemia cell activation and proliferation.Haematologica
Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis.Haematologica
Efficacy of continuous zanubrutinib monotherapy versus fixed-duration acalabrutinib plus venetoclax or venetoclax plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia: a network meta-analysis.Leukemia & lymphoma
How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence From the Targeted Therapy Era.Clinical lymphoma, myeloma & leukemia
Social vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area.Cancer research communications
Borderline tuberculoid leprosy with type 1 reaction mimicking leukaemia cutis in a patient with chronic lymphocytic leukaemia on acalabrutinib.BMJ case reports
Optimizing CLL treatment after covalent BTK inhibition.Clinical advances in hematology & oncology : H&O
Case reportZanubrutinib Combined With Venetoclax for the Treatment of Central Nervous System-Involved Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case Report.Cancer reports (Hoboken, N.J.)
Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.Blood
ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine